US 12,421,226 B2
Heteroaryl compounds as necrosis inhibitors, composition and method using the same
Xiaohu Zhang, Suzhou (CN); Sudan He, Suzhou (CN); and Haikuo Ma, Suzhou (CN)
Assigned to Accro Bioscience (HK) Limited, Wan Chai (HK)
Appl. No. 17/422,168
Filed by Accro Bioscience (HK), Wan Chai (HK); and Xiaohu Zhang, Suzhou (CN)
PCT Filed Jan. 11, 2020, PCT No. PCT/US2020/013258
§ 371(c)(1), (2) Date Jul. 9, 2021,
PCT Pub. No. WO2020/146858, PCT Pub. Date Jul. 16, 2020.
Claims priority of application No. 201910026967.X (CN), filed on Jan. 11, 2019.
Prior Publication US 2022/0112188 A1, Apr. 14, 2022
Int. Cl. C07D 471/04 (2006.01); C07D 417/14 (2006.01); C07D 495/04 (2006.01); C07D 513/04 (2006.01); C07D 519/00 (2006.01)
CPC C07D 471/04 (2013.01) [C07D 417/14 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01)] 4 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a stereoisomer, hydrate, solvate, co-crystal, or tautomer, or pharmaceutically acceptable salt thereof.